Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China
· Delayed Price · Currency is CNY 48.63
+1.68 (3.58%)
At close: Mar 9, 2026
SHE:301096 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,274 | 4,115 | 7,091 | 7,389 | 9,293 | - | Upgrade
|
| Market Cap Growth | 30.83% | -41.97% | -4.04% | -20.49% | - | - | Upgrade
|
| Enterprise Value | 5,768 | 4,256 | 6,460 | 6,057 | 9,416 | - | Upgrade
|
| Last Close Price | 48.63 | 37.94 | 64.78 | 67.17 | 83.80 | - | Upgrade
|
| PE Ratio | - | - | 26.07 | 38.06 | 83.65 | - | Upgrade
|
| Forward PE | - | 12.33 | 21.10 | 26.68 | - | - | Upgrade
|
| PS Ratio | 8.93 | 5.13 | 6.97 | 12.17 | 24.83 | - | Upgrade
|
| PB Ratio | 2.04 | 1.60 | 2.64 | 2.98 | 4.01 | - | Upgrade
|
| P/TBV Ratio | 2.11 | 1.66 | 2.74 | 3.08 | 4.12 | - | Upgrade
|
| P/OCF Ratio | - | - | 78.39 | 28.48 | 63.90 | - | Upgrade
|
| EV/Sales Ratio | 9.77 | 5.31 | 6.35 | 9.97 | 25.15 | - | Upgrade
|
| EV/EBITDA Ratio | - | 43.41 | 18.51 | 33.90 | 67.75 | - | Upgrade
|
| EV/EBIT Ratio | - | - | 24.75 | 49.50 | 84.55 | - | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.28 | 0.14 | 0.00 | 0.12 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | - | 7.23 | 1.05 | 0.05 | 1.93 | 2.18 | Upgrade
|
| Net Debt / Equity Ratio | 0.19 | 0.08 | -0.19 | -0.49 | -0.75 | 0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -307.79 | 2.04 | -1.46 | -6.88 | -12.45 | 0.29 | Upgrade
|
| Net Debt / FCF Ratio | -1.77 | -0.34 | 0.86 | 3.70 | 16.80 | -0.10 | Upgrade
|
| Asset Turnover | 0.15 | 0.22 | 0.31 | 0.21 | 0.21 | 0.41 | Upgrade
|
| Inventory Turnover | 1.99 | 2.88 | 4.42 | 4.46 | 9.26 | 23.08 | Upgrade
|
| Quick Ratio | 1.42 | 1.64 | 1.68 | 5.15 | 4.53 | 1.66 | Upgrade
|
| Current Ratio | 1.77 | 2.01 | 1.90 | 5.54 | 4.71 | 1.96 | Upgrade
|
| Return on Equity (ROE) | -7.03% | -2.01% | 10.53% | 8.09% | 8.35% | 18.48% | Upgrade
|
| Return on Assets (ROA) | -3.04% | -0.77% | 4.95% | 2.61% | 3.91% | 6.60% | Upgrade
|
| Return on Invested Capital (ROIC) | -6.19% | -1.85% | 14.02% | 13.30% | 21.91% | 15.61% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.40% | -1.50% | 9.20% | 4.60% | 4.50% | 10.40% | Upgrade
|
| Earnings Yield | -3.57% | -1.28% | 3.84% | 2.63% | 1.20% | - | Upgrade
|
| FCF Yield | -5.29% | -14.36% | -8.44% | -4.50% | -1.11% | - | Upgrade
|
| Dividend Yield | - | - | 0.46% | 1.19% | 0.72% | - | Upgrade
|
| Payout Ratio | - | - | 34.12% | 34.28% | 9.11% | 15.20% | Upgrade
|
| Buyback Yield / Dilution | 4.73% | 0.66% | 0.11% | -33.77% | -0.29% | -9.26% | Upgrade
|
| Total Shareholder Return | 4.73% | 0.66% | 0.57% | -32.58% | 0.42% | -9.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.